AAPL299.11+2.10 (+0.71%) ▲|ABBV234.85+4.84 (+2.10%) ▲|ABT90.75+2.92 (+3.32%) ▲|ACN126.82+1.99 (+1.59%) ▲|ADBE199.47+4.57 (+2.34%) ▲|AMAT586.25-53.93 (-8.42%) ▼|AMD520.90-30.73 (-5.57%) ▼|AMGN347.78+3.06 (+0.89%) ▲|AMT178.42+1.99 (+1.13%) ▲|AMZN234.44+1.65 (+0.71%) ▲|AVGO383.75-8.39 (-2.14%) ▼|AXP337.06-1.01 (-0.30%) ▼|BA218.49-2.34 (-1.06%) ▼|BAC57.79+0.42 (+0.72%) ▲|BKNG169.51+1.74 (+1.04%) ▲|BLK1,020.11-31.64 (-3.01%) ▼|BMY55.68+0.98 (+1.79%) ▲|BNY147.89+1.45 (+0.99%) ▲|BRK-B493.60+4.91 (+1.00%) ▲|C145.37-0.30 (-0.21%) ▼|CAT989.58-32.71 (-3.20%) ▼|CL91.38+2.71 (+3.05%) ▲|CMCSA22.89+0.57 (+2.53%) ▲|COF198.39-2.31 (-1.15%) ▼|COP110.28+0.58 (+0.52%) ▲|COST961.01+9.66 (+1.02%) ▲|CRM154.87+4.75 (+3.16%) ▲|CSCO121.81+0.28 (+0.23%) ▲|CVS101.33+0.03 (+0.03%) ▲|CVX176.14+1.08 (+0.61%) ▲|DE598.59+0.00 (+0.00%) ▲|DHR178.54+0.35 (+0.20%) ▲|DIS103.44+0.99 (+0.96%) ▲|DUK125.06+1.54 (+1.25%) ▲|EMR144.51-5.71 (-3.80%) ▼|FDX323.30-5.48 (-1.67%) ▼|GD349.10+5.74 (+1.67%) ▲|GE357.08+1.96 (+0.55%) ▲|GEV1,048.85-78.74 (-6.98%) ▼|GILD125.78+0.91 (+0.73%) ▲|GM80.08-0.35 (-0.44%) ▼|GOOG346.84-1.95 (-0.56%) ▼|GOOGL347.35-2.21 (-0.63%) ▼|GS1,099.08-7.29 (-0.66%) ▼|HD325.50-1.13 (-0.34%) ▼|HON224.66-3.46 (-1.51%) ▼|IBM265.84+13.62 (+5.40%) ▲|INTC133.70-7.24 (-5.14%) ▼|INTU260.76+2.99 (+1.16%) ▲|ISRG401.54-1.42 (-0.35%) ▼|JNJ237.14+5.85 (+2.53%) ▲|JPM334.13+2.65 (+0.80%) ▲|KO79.93+0.40 (+0.50%) ▲|LIN517.00+0.29 (+0.06%) ▲|LLY1,104.37+2.29 (+0.21%) ▲|LMT502.25+8.65 (+1.75%) ▲|LOW214.90+0.50 (+0.23%) ▲|LRCX370.97-38.57 (-9.42%) ▼|MA488.32+4.23 (+0.87%) ▲|MCD271.75+1.65 (+0.61%) ▲|MDLZ60.66+1.15 (+1.92%) ▲|MDT80.36+1.09 (+1.38%) ▲|META564.45+0.60 (+0.11%) ▲|MMM162.40-0.82 (-0.50%) ▼|MO71.12+1.61 (+2.32%) ▲|MRK118.74+3.26 (+2.82%) ▲|MS227.48+0.39 (+0.17%) ▲|MSFT372.72+5.38 (+1.46%) ▲|MU1,072.68-138.70 (-11.45%) ▼|NEE86.58+0.50 (+0.58%) ▲|NFLX73.19+0.31 (+0.42%) ▲|NKE42.94-0.25 (-0.58%) ▼|NOW97.36+4.35 (+4.67%) ▲|NVDA201.83-6.82 (-3.27%) ▼|ORCL168.27-6.80 (-3.88%) ▼|PEP141.06+0.35 (+0.25%) ▲|PFE25.01-0.08 (-0.30%) ▼|PG150.60+2.92 (+1.98%) ▲|PLTR118.86-0.64 (-0.54%) ▼|PM177.91+4.74 (+2.74%) ▲|QCOM201.15-20.75 (-9.35%) ▼|RTX184.92+3.09 (+1.70%) ▲|SBUX100.89+0.74 (+0.74%) ▲|SCHW93.03+1.00 (+1.09%) ▲|SO94.60+1.17 (+1.25%) ▲|SPG216.71+2.14 (+1.00%) ▲|T22.87+0.77 (+3.48%) ▲|TMO466.82+2.81 (+0.61%) ▲|TMUS183.26+3.20 (+1.78%) ▲|TSLA384.06-20.99 (-5.18%) ▼|TXN302.80-29.48 (-8.87%) ▼|UBER70.55-0.88 (-1.23%) ▼|UNH407.91+1.23 (+0.30%) ▲|UNP260.49+0.58 (+0.22%) ▲|UPS106.18-1.06 (-0.99%) ▼|USB59.74+1.06 (+1.81%) ▲|V331.10+4.50 (+1.38%) ▲|VZ46.60+1.24 (+2.73%) ▲|WFC83.83-0.01 (-0.01%) ▼|WMT119.53+2.35 (+2.01%) ▲|XOM140.15+1.68 (+1.21%) ▲|AAPL299.11+2.10 (+0.71%) ▲|ABBV234.85+4.84 (+2.10%) ▲|ABT90.75+2.92 (+3.32%) ▲|ACN126.82+1.99 (+1.59%) ▲|ADBE199.47+4.57 (+2.34%) ▲|AMAT586.25-53.93 (-8.42%) ▼|AMD520.90-30.73 (-5.57%) ▼|AMGN347.78+3.06 (+0.89%) ▲|AMT178.42+1.99 (+1.13%) ▲|AMZN234.44+1.65 (+0.71%) ▲|AVGO383.75-8.39 (-2.14%) ▼|AXP337.06-1.01 (-0.30%) ▼|BA218.49-2.34 (-1.06%) ▼|BAC57.79+0.42 (+0.72%) ▲|BKNG169.51+1.74 (+1.04%) ▲|BLK1,020.11-31.64 (-3.01%) ▼|BMY55.68+0.98 (+1.79%) ▲|BNY147.89+1.45 (+0.99%) ▲|BRK-B493.60+4.91 (+1.00%) ▲|C145.37-0.30 (-0.21%) ▼|CAT989.58-32.71 (-3.20%) ▼|CL91.38+2.71 (+3.05%) ▲|CMCSA22.89+0.57 (+2.53%) ▲|COF198.39-2.31 (-1.15%) ▼|COP110.28+0.58 (+0.52%) ▲|COST961.01+9.66 (+1.02%) ▲|CRM154.87+4.75 (+3.16%) ▲|CSCO121.81+0.28 (+0.23%) ▲|CVS101.33+0.03 (+0.03%) ▲|CVX176.14+1.08 (+0.61%) ▲|DE598.59+0.00 (+0.00%) ▲|DHR178.54+0.35 (+0.20%) ▲|DIS103.44+0.99 (+0.96%) ▲|DUK125.06+1.54 (+1.25%) ▲|EMR144.51-5.71 (-3.80%) ▼|FDX323.30-5.48 (-1.67%) ▼|GD349.10+5.74 (+1.67%) ▲|GE357.08+1.96 (+0.55%) ▲|GEV1,048.85-78.74 (-6.98%) ▼|GILD125.78+0.91 (+0.73%) ▲|GM80.08-0.35 (-0.44%) ▼|GOOG346.84-1.95 (-0.56%) ▼|GOOGL347.35-2.21 (-0.63%) ▼|GS1,099.08-7.29 (-0.66%) ▼|HD325.50-1.13 (-0.34%) ▼|HON224.66-3.46 (-1.51%) ▼|IBM265.84+13.62 (+5.40%) ▲|INTC133.70-7.24 (-5.14%) ▼|INTU260.76+2.99 (+1.16%) ▲|ISRG401.54-1.42 (-0.35%) ▼|JNJ237.14+5.85 (+2.53%) ▲|JPM334.13+2.65 (+0.80%) ▲|KO79.93+0.40 (+0.50%) ▲|LIN517.00+0.29 (+0.06%) ▲|LLY1,104.37+2.29 (+0.21%) ▲|LMT502.25+8.65 (+1.75%) ▲|LOW214.90+0.50 (+0.23%) ▲|LRCX370.97-38.57 (-9.42%) ▼|MA488.32+4.23 (+0.87%) ▲|MCD271.75+1.65 (+0.61%) ▲|MDLZ60.66+1.15 (+1.92%) ▲|MDT80.36+1.09 (+1.38%) ▲|META564.45+0.60 (+0.11%) ▲|MMM162.40-0.82 (-0.50%) ▼|MO71.12+1.61 (+2.32%) ▲|MRK118.74+3.26 (+2.82%) ▲|MS227.48+0.39 (+0.17%) ▲|MSFT372.72+5.38 (+1.46%) ▲|MU1,072.68-138.70 (-11.45%) ▼|NEE86.58+0.50 (+0.58%) ▲|NFLX73.19+0.31 (+0.42%) ▲|NKE42.94-0.25 (-0.58%) ▼|NOW97.36+4.35 (+4.67%) ▲|NVDA201.83-6.82 (-3.27%) ▼|ORCL168.27-6.80 (-3.88%) ▼|PEP141.06+0.35 (+0.25%) ▲|PFE25.01-0.08 (-0.30%) ▼|PG150.60+2.92 (+1.98%) ▲|PLTR118.86-0.64 (-0.54%) ▼|PM177.91+4.74 (+2.74%) ▲|QCOM201.15-20.75 (-9.35%) ▼|RTX184.92+3.09 (+1.70%) ▲|SBUX100.89+0.74 (+0.74%) ▲|SCHW93.03+1.00 (+1.09%) ▲|SO94.60+1.17 (+1.25%) ▲|SPG216.71+2.14 (+1.00%) ▲|T22.87+0.77 (+3.48%) ▲|TMO466.82+2.81 (+0.61%) ▲|TMUS183.26+3.20 (+1.78%) ▲|TSLA384.06-20.99 (-5.18%) ▼|TXN302.80-29.48 (-8.87%) ▼|UBER70.55-0.88 (-1.23%) ▼|UNH407.91+1.23 (+0.30%) ▲|UNP260.49+0.58 (+0.22%) ▲|UPS106.18-1.06 (-0.99%) ▼|USB59.74+1.06 (+1.81%) ▲|V331.10+4.50 (+1.38%) ▲|VZ46.60+1.24 (+2.73%) ▲|WFC83.83-0.01 (-0.01%) ▼|WMT119.53+2.35 (+2.01%) ▲|XOM140.15+1.68 (+1.21%) ▲|
20.6 C
New York
Tuesday, June 23, 2026

Tag: website

Dietz & Watson Expands Its Premium Deli Chicken Lineup with Launch of Heritage Roast and Cantina Chicken Breast at IDDBA 2026

New sliced-to-order flavors deliver comforting tradition and vibrant, globally inspired taste
New sliced-to-order flavors deliver comforting tradition and vibrant, globally inspired taste

MemeToro Price Prediction: $1 Talk Returns as Presale Buyers Bet on MemeToro AI Agent Solutions

ZURICH, June 07, 2026 (GLOBE NEWSWIRE) -- The cryptocurrency market is witnessing a massive convergence of artificial intelligence and digital culture. Investors are shifting capital toward functional crypto ecosystems. Memecoins have evolved far beyond basic internet jokes.

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk...

Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of the strongest US pharmaceutical launches by...

PUDO Inc announces earnings call for FY 2026 year end results

TORONTO, June 3, 2026 /CNW/ - PUDO Inc. ("PUDO" or the "Company") (CSE: PDO) (OTCQB: PDPTF), today announced that it will report its year...

Vision Insurance After Retirement (2026): VSP Vision Care Named Leading Option for Retiree Eye Coverage by Expert Consumers

NEW YORK, June 7, 2026 /PRNewswire/ -- A recent analysis from Expert Consumers highlights VSP® Vision Care as a leading option for vision insurance...

Cyndee Haydon Named Among 2026 Best Real Estate Agents in the United States by RealTrends, Ranking #723 in Florida Out of 232,000 Realtors

Pinellas Gulf Beach vacation rental and STR investment specialist places in the top 0.3% of residential real estate professionals in Florida, based on independently verified 2025 sales data
Pinellas Gulf Beach vacation rental and STR investment specialist places in the top 0.3% of residential real estate professionals in Florida, based on independently verified 2025 sales data

Her Bodhi Claims Evaluated: What Research Reveals About This Primal Queen Alternative, Weight Loss Support and Consumer Reviews

An independent, research-informed evaluation of the Her Bodhi botanical formula — examining its ingredient benefits, weight loss positioning, menopause wellness support, disclosed side effects, and publicly available consumer feedback.
An independent, research-informed evaluation of the Her Bodhi botanical formula — examining its ingredient benefits, weight loss positioning, menopause wellness support, disclosed side effects, and publicly available consumer feedback.

Leading Vision Insurance for Glasses (2026): VSP Individual Vision Plans Named Top Plan for Frames and Lens Coverage by Better Business Advice

NEW YORK, June 6, 2026 /PRNewswire/ -- VSP® Individual Vision Plans has been recognized by Better Business Advice as a top vision insurance option...

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978 

InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering

New York, NY, June 05, 2026 (GLOBE NEWSWIRE) -- InterPrivate Investment Partners V, Inc. (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, announced the closing of its initial public offering of 20,125,000 units, including 2,625,000 units issued pursuant to the exercise of the underwriters’ over-allotment option in full, at a price of $10.00 per unit on June 5, 2026. Total gross proceeds from the offering were $201.25 million before deducting underwriting discounts and commissions and other offering expenses payable by the Company.

Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control

Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass...

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. (WGS)

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Connecticut on behalf of all persons or entities who purchased or otherwise acquired GeneDx Holdings Corp. (“WGS” or the “Company”) (NASDAQ: WGS) securities between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”).

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsWebsite